Unfortunately have to agree with you super.
But if Phase II results are good and we get a Big Pharma injecting cash for Phase III and taking a stake, we will get re-rated. That is my ideal scenario as SP will go up and we share in upside before eventual takeover rather than a lowball bid next year.
They should then look at a NASDAQ listing to get some extra 'froth'
Buy Orders Stacking up, page-20
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.002(2.04%) |
Mkt cap ! $22.79M | |||
| Open | High | Low | Value | Volume |
| 9.5¢ | 10.0¢ | 9.5¢ | $63.51K | 640.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 127000 | 9.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 171190 | 4 |
View Market Depth
| Last trade - 15.48pm 16/07/2024 (20 minute delay) ? |
| IMC (ASX) Chart |